465 Aspartate is a primary nitrogen source for Mycobacterium tuberculosis during infection, being required for virulence after entering cells via the amino acid transporter AnsP1.
http://www.nature.com/nchembio/journal/v9/n11/abs/nchembio.1355.html
464 Tenascin-C is an innate broad-spectrum, HIV-1–neutralizing protein in breast milk.
http://www.pnas.org/content/110/45/18220.abstract
463 Vaccines based on structure-based design provide protection against infectious diseases. (Review).
http://www.expert-reviews.com/doi/abs/10.1586/14760584.2013.840092
462 Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus.
http://www.sciencemag.org/content/342/6158/592.abstract
461 A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation.
http://www.pnas.org/content/110/44/17981.abstract
460 Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure.
http://www.cell.com/abstract/S0092-8674(13)01157-4
459 Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys.
http://www.cell.com/abstract/S0092-8674(13)01280-4
458 Bacteria engineered to use nonstandard amino acids show increased resistance to bacteriophage attack.
http://www.sciencemag.org/content/342/6156/357.abstract
457 The Bacterial Effector VopL Organizes Actin into Filament-like Structures.
http://www.cell.com/abstract/S0092-8674(13)01156-2
456 Macrophages lift off surface-bound bacteria using a filopodium-lamellipodium hook-and-shovel mechanism.
http://www.nature.com/srep/2013/131007/srep02884/full/srep02884.html
|
